Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 27.


Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Weston, Jennifer, Dundar, Yenal, Nevitt, Sarah J ORCID: 0000-0001-9988-2709 and Marson, Anthony G ORCID: 0000-0002-6861-8806
(2020) Antiepileptic drugs as prophylaxis for postcraniotomy seizures. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 4 (4). CD007286-.


Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Weston, Jennifer, Dundar, Yenal, Nevitt, Sarah J ORCID: 0000-0001-9988-2709 and Marson, Anthony G ORCID: 0000-0002-6861-8806
(2018) Antiepileptic drugs as prophylaxis for postcraniotomy seizures (Review). COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 5 (5). CD007286-.


Aslam, RW ORCID: 0000-0002-0916-9641, Bates, V, Dundar, Yenal, Hounsome, Juliet ORCID: 0000-0002-2026-3778, Richardson, Marty ORCID: 0000-0002-7097-8704, Krishan, Ashma, Dickson, Rumona ORCID: 0000-0003-1416-0913, Boland, Angela ORCID: 0000-0002-5435-8644, Kotas, Eleanor, Fisher, Joanne
et al (show 2 more authors) (2016) Automated tests for diagnosing and monitoring cognitive impairment: a diagnostic accuracy review. Health Technology Assessment, 20 (77). 1-+.


Stainthorpe, Angela ORCID: 0000-0002-2531-9371, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty ORCID: 0000-0002-7097-8704, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie ORCID: 0000-0003-0164-103X, Dundar, Yenal, McEntee, Joanne and Syndikus, Isabel
(2020) Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 4 (4). pp. 563-574.


Fleeman, Nigel ORCID: 0000-0002-4637-9779, Stainthorpe, Angela, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty ORCID: 0000-0002-7097-8704, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie, Dundar, Yenal, Kotas, Eleanor, McEntee, Joanne and Isabel, Syndikus
(2018) Brentuximab vedotin for treating relapsed or refractory CD30-positive cutaneous T-cell lymphoma (17/56/12). [Report]


Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Duarte, Rui, Boland, Angela ORCID: 0000-0002-5435-8644, Kotas, Eleanor, Dundar, Yenal, McEntee, Joanne and Ahmad, Sajjad
(2019) Cenegermin for Treating Neurotrophic Keratitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 3 (4). pp. 453-461.


Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dickson, Rumona ORCID: 0000-0003-1416-0913, Dwan, Kerry, Richardson, Marty ORCID: 0000-0002-7097-8704, Dundar, Yenal, Davis, Helen and Banks, Lindsay
(2015) Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group Perspective. PHARMACOECONOMICS, 33 (9). pp. 893-904.


Houten, Rachel ORCID: 0000-0002-4315-7732, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Mahon, James, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Lambe, Tosin ORCID: 0000-0002-6229-2454, Dundar, Yenal, Kotas, Eleanor and McEntee, Joanne
(2021) Encorafenib with Binimetinib for the Treatment of Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 5 (1). pp. 13-22.


Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Bagust, Adrian ORCID: 0000-0002-2142-5767, Boland, Angela ORCID: 0000-0002-5435-8644, Dwan, Kerry, Beale, Sophie ORCID: 0000-0003-0164-103X, Hockenhull, Juliet ORCID: 0000-0002-2026-3778, Proudlove, Christine, Dundar, Yenal, Richardson, Marty ORCID: 0000-0002-7097-8704, Dickson, Rumona ORCID: 0000-0003-1416-0913
et al (show 2 more authors) (2015) Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 19 (47). I-133.


Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Boland, Angela ORCID: 0000-0002-5435-8644, Bates, Victoria ORCID: 0000-0001-7211-5403, Vecchio, Fabio, Dundar, Yenal, Chaplin, Marty ORCID: 0000-0002-7097-8704 and Green, John A
(2021) First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 3 (3). CD010383-.


Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Dwan, Kerry, Boland, Angela ORCID: 0000-0002-5435-8644, Bates, Victoria, Vecchio, Fabio, Dundar, Yenal, Jain, Pooja and Green, John A
(2016) First‐line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non‐squamous non‐small cell lung cancer. Cochrane Database of Systematic Reviews, 2016 (5). CD010383-.


Fleeman, Nigel ORCID: 0000-0002-4637-9779, Dundar, Yenal, Shah, Prakesh S and Shaw, Ben NJ
(2019) Heated Humidified High-Flow Nasal Cannula for Preterm Infants: An Updated Systematic Review and Meta-analysis. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 35 (4). pp. 298-306.


Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Bagust, Adrian ORCID: 0000-0002-2142-5767, Richardson, Marty ORCID: 0000-0002-7097-8704, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Hounsome, Juliet ORCID: 0000-0002-2026-3778, Duarte, Rui
et al (show 1 more authors) (2020) Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 24 (2). 1-+.


Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Lambe, Tosin, Nevitt, Sarah, Mahon, James, Boland, Angela, Beale, Sophie, Dundar, Yenal, Edwards, Katherine, Bresnahan, Rebecca, McEntee, Joanne
et al (show 1 more authors) (2020) Midostaurin for treating advanced systemic mastocytosis [ID1573]. [Report]


Protogerou, Cleo, Fleernan, Nigel, Dwan, Kerry, Richardson, Marty ORCID: 0000-0002-7097-8704, Dundar, Yenal and Hagger, Martin S
(2015) Moderators of the effect of psychological interventions on depression and anxiety in cardiac surgery patients: A systematic review and meta-analysis. BEHAVIOUR RESEARCH AND THERAPY, 73. pp. 151-164.


Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Mahon, James, Nevitt, Sarah, Bresnahan, Rebecca, Boland, Angela, Beale, Sophie, Lambe, Tosin, Bhattacharyya, Devarshi, Dundar, Yenal, McEntee, Joanne
et al (show 1 more authors) (2021) Nivolumab in combination with chemotherapy for untreated advanced gastric, gastro-oesophageal junction, or oesophageal adenocarcinoma [ID1465]. [Report]


Chaplin, Marty ORCID: 0000-0002-7097-8704, Bresnahan, Rebecca, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Houten, Rachel ORCID: 0000-0002-4315-7732, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Marsden, Ashley and Munot, Pinki
(2023) Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15. PharmacoEconomics - Open, 7 (6). pp. 863-875.


Bresnahan, Rebecca, Houten, Rachel ORCID: 0000-0002-4315-7732, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Mahon, James, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Bhattacharyya, Devarshi, Dundar, Yenal, McEntee, Joanne
et al (show 3 more authors) (2023) Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics - open, 7 (4). pp. 525-536.


Bresnahan, Rebecca, Houten, Rachel, Mahon, James, Beale, Sophie, Nevitt, Sarah, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Bhattacharyya, Devarshi, Dundar, Yenal, McEntee, Joanne and Gandhi, Shreyans
(2021) Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuria [ID3746]. [Report]


Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Beale, Sophie ORCID: 0000-0003-0164-103X, Dwan, Kerry, Dickson, Rumona ORCID: 0000-0003-1416-0913, Proudlove, Chris and Dundar, Yenal
(2015) Pertuzumab in Combination with Trastuzumab and Docetaxel for the Treatment of HER2-Positive Metastatic or Locally Recurrent Unresectable Breast Cancer. PHARMACOECONOMICS, 33 (1). pp. 13-23.


Dundar, Yenal, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Richardson, Marty ORCID: 0000-0002-7097-8704 and Dwan, Kerry
(2016) Pharmacological treatment of acute agitation associated with psychotic and bipolar disorder: a systematic review and meta-analysis. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 31 (4). pp. 268-285.


Houten, Rachel ORCID: 0000-0002-4315-7732, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Chaplin, Marty ORCID: 0000-0002-7097-8704, Edwards, Katherine, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Marsden, Ashley, Malik, Zafar
et al (show 1 more authors) (2023) Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 7 (3). pp. 345-358.


Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Mahon, James, Houten, Rachel, Edwards, Katherine, Donegan, Sarah, Boland, Angela, Beale, Sophie, Dundar, Yenal and Mcentee, Joanne
(2023) Upadacitinib for treating moderately to severely active ulcerative colitis [ID3953]. [Report]


Nicholson, Amanda, Mahon, James, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie ORCID: 0000-0003-0164-103X, Dwan, Kerry, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Hockenhull, Juliet ORCID: 0000-0002-2026-3778 and Dundar, Yenal
(2015) The clinical effectiveness and cost-effectiveness of the PROGENSA (R) prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation. Health Technology Assessment, 19 (87). 1-+.


Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty ORCID: 0000-0002-7097-8704, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Duarte, Rui and Shenoy, Aditya
(2019) A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine. BMC CANCER, 19 (1). 1209-.


Aslam, Rabeea'h W ORCID: 0000-0002-0916-9641, Bates, Vickie, Dundar, Yenal, Hounsome, Juliet ORCID: 0000-0002-2026-3778, Richardson, Marty ORCID: 0000-0002-7097-8704, Krishan, Ashma, Dickson, Rumona ORCID: 0000-0003-1416-0913, Boland, Angela ORCID: 0000-0002-5435-8644, Fisher, Joanne, Robinson, Louise
et al (show 1 more authors) (2018) A systematic review of the diagnostic accuracy of automated tests for cognitive impairment. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 33 (4). pp. 561-575.


Ghattaoraya, Gurpreet S ORCID: 0000-0003-4809-7342, Dundar, Yenal ORCID: 0000-0002-9847-1622, González-Galarza, Faviel F, Maia, Maria Helena Thomaz, Santos, Eduardo José Melo, da Silva, Andréa Luciana Soares, McCabe, Antony ORCID: 0000-0003-3089-3674, Middleton, Derek, Alfirevic, Ana ORCID: 0000-0002-2801-9817, Dickson, Rumona ORCID: 0000-0003-1416-0913
et al (show 1 more authors) (2016) A web resource for mining HLA associations with adverse drug reactions: HLA-ADR. Database : the journal of biological databases and curation, 2016. baw069-.

This list was generated on Sat Apr 13 17:22:25 2024 BST.